New Study Using Live Virus Explores Whether Pfizer-BioNTech Vaccine Protects Against Variants

The results are encouraging, but we must err on the side of caution and conduct more elaborate studies before ruling that the first generation of vaccines is variant-proof.

Read the full post on Forbes - Healthcare